Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal
Author:
Affiliation:
1. IIS-Fundacion Jimenez Diaz, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain
2. Fundacion Renal Iñigo Alvarez de Toledo-IRSIN, Madrid, Spain
3. REDINREN, Madrid, Spain
Abstract
Funder
FIS
ERA-PerMed-JTC2018
KIDNEY ATTACK
PERSTIGAN
ISCIII-RETIC REDinREN
Fondos FEDER, FRIAT, Sociedad Española de Nefrología, Comunidad de Madrid
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Link
http://academic.oup.com/ckj/article-pdf/12/5/629/30088250/sfz127.pdf
Reference26 articles.
1. Primary membranous nephropathy;Couser;Clin J Am Soc Nephrol,2017
2. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy;Tomas;N Engl J Med,2014
3. Rituximab or cyclosporine in the treatment of membranous nephropathy;Fervenza;N Engl J Med,2019
4. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis;Kidney Int Suppl,2012
5. Rituximab for idiopathic membranous nephropathy;Remuzzi;Lancet,2002
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of cyclophosphamide combined with glucocorticoid therapy on idiopathic membranous nephropathy: A multicenter open-label randomized controlled trial;Clinical Nephrology;2024-07-01
2. Alterations of B-Cell subsets in Peripheral Blood from Adult Patients with Idiopathic Membranous Nephropathy;Immunology Letters;2024-04
3. Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy;BMC Nephrology;2024-03-06
4. Glomérulonéphrite extramembraneuse : outils diagnostiques, pronostiques et d’aide à la décision thérapeutique;Revue Francophone des Laboratoires;2024-03
5. Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up;Journal of Nephrology;2023-11-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3